Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5201475
Max Phase: Preclinical
Molecular Formula: C40H43N3O10S
Molecular Weight: 757.86
Associated Items:
ID: ALA5201475
Max Phase: Preclinical
Molecular Formula: C40H43N3O10S
Molecular Weight: 757.86
Associated Items:
Canonical SMILES: COc1cc2c(cc1O)CCC[C@]21SC2C3=C(C4OCOC4=C(C)C3OC(C)=O)[C@@H](COC1=O)N1[C@@H](C#N)[C@@H]3Cc4cc(C)c(OC)c(O)c4[C@H]([C@H]21)N3C
Standard InChI: InChI=1S/C40H43N3O10S/c1-17-10-21-11-23-24(14-41)43-25-15-50-39(47)40(9-7-8-20-12-26(45)27(48-5)13-22(20)40)54-38(32(43)31(42(23)4)28(21)33(46)34(17)49-6)30-29(25)37-36(51-16-52-37)18(2)35(30)53-19(3)44/h10,12-13,23-25,31-32,35,37-38,45-46H,7-9,11,15-16H2,1-6H3/t23-,24-,25+,31+,32+,35?,37?,38?,40-/m0/s1
Standard InChI Key: GCKADCHHHHAWEV-JXYNDGDBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 757.86 | Molecular Weight (Monoisotopic): 757.2669 | AlogP: 4.06 | #Rotatable Bonds: 3 |
Polar Surface Area: 160.25 | Molecular Species: NEUTRAL | HBA: 14 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 9.15 | CX Basic pKa: 5.71 | CX LogP: 3.75 | CX LogD: 3.74 |
Aromatic Rings: 2 | Heavy Atoms: 54 | QED Weighted: 0.34 | Np Likeness Score: 1.49 |
1. Fang Y, Li H, Ji B, Cheng K, Wu B, Li Z, Zheng C, Hua H, Li D.. (2021) Renieramycin-type alkaloids from marine-derived organisms: Synthetic chemistry, biological activity and structural modification., 210 [PMID:33333398] [10.1016/j.ejmech.2020.113092] |
Source(1):